Skip to main content
Skip to section navigation
Skip to footer
Home
About Us
Platform
Pipeline
Clinical Trials
Investors
Overview
News & Events
Company Info
Financial Results
Stock Data
SEDAR
SEC Filings
Governance
Connect
SEC Filings
To view the webinar replay of “PRECISE-AD Phase 1b Blinded Interim Data Analysis"
Click Here
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Results
Stock Data
NASDAQ: PMN
Analyst Coverage
SEDAR
SEC Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Filing Type:
View All
10-12B
10-12B/A
10-K
10-K/A
10-Q
3
4
4/A
424B3
424B5
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
REGDEX
S-1
S-1/A
S-3
S-3/A
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF ACTION
SEC STAFF LETTER
SUPPL
UPLOAD
Year:
View All
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
Date
Form
Description
PDF
Pages
01/02/24
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Documents
expand_more
EX-99.1
6
01/02/24
4
Statement of changes in beneficial ownership of securities
2
12/27/23
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Documents
expand_more
EX-99.1
6
12/27/23
3
Initial statement of beneficial ownership of securities
1
12/27/23
3
Initial statement of beneficial ownership of securities
1
12/08/23
8-K
Current report filing
Documents
expand_more
EX-3.1
EX-10.1
28
11/20/23
8-K
Current report filing
Documents
expand_more
EX-99.1
4
11/14/23
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
expand_more
EX-31.1
EX-31.2
EX-32.1
37
11/14/23
8-K
Current report filing
Documents
expand_more
EX-99.1
8
10/30/23
4
Statement of changes in beneficial ownership of securities
1
arrow_back
1…
15
16
17
18
19
20
21
22
23
24
…37
arrow_forward
Email Alerts
Contacts